Country for PR: United Kingdom
Contributor: PR Newswire Europe
Monday, August 23 2021 - 23:00
AsiaNet
Excelra launches a re-envisioned version of GOSTAR, its structure-activity relationship application, with an innovative set of new features to accelerate the drug discovery cycle
HYDERABAD, India, Aug. 23 /PRNewswire-AsiaNet/ --

    Today, Excelra [https://www.excelra.com/], a global data science and data 
analytics company, unveiled an improved version of GOSTAR 
[https://www.gostardb.com/], its flagship chemistry insights engine. The 
enhancements offer advanced search, analysis, and visualization capabilities 
enabling drug discovery scientists to accelerate the hit identification and 
lead optimization process. 

    "Drug discovery researchers need to ensure that they are getting the 
broadest possible view of structure-activity data while being able to readily 
drill down to the most meaningful data points. The new GOSTAR version has been 
re-envisioned based on extensive user feedback to provide researchers with an 
intuitive interface that reduces time to market for new drugs. It incorporates 
analytical capabilities, eliminating the need to use multiple tools to assess 
compounds while also providing insights directly within the application. The 
result is a rapid and more confident decision-making process," said Norman 
Azoulay, Director, Scientific Products. 

    GOSTAR's industry-leading capabilities include: 
    - Advanced Search: Discover insights faster with dynamic, flexible, and 
interactive search capabilities 
    - SAR View: View, sort, and export structures based on activity against 
targets of interest 
    - Analytics: Compare compounds and perform Molecular pair, maximum common 
substructure, and ligand efficiency vs. ligand-lipophilicity efficiency analyses

    All data in GOSTAR, which now includes over 8 million compounds, along with 
bioactivity data, is subjected to a three-tiered, QMS-ISO certified quality 
control process. The standardization and normalization of all data provide 
additional clarity while ensuring it is directly and readily comparable.

    "Excelra aims to transform life science data into actionable insights for 
our R&D clients that help them to innovate and accelerate their drug discovery. 
The enhancements made to GOSTAR will improve the ability to make meaningful 
predictions and lead to more promising pipelines," said Anandbir Singh Brar, 
CEO, Excelra. 

    GOSTAR is available as an application for users to seek, find, and discover 
compounds. In addition, it is offered via APIs and as a downloadable dataset to 
power in-house libraries and machine learning models.

    For more information about GOSTAR, visit www.gostardb.com

    About Excelra

    Excelra's data and analytics solutions empower innovation in life sciences 
from molecule to market. The Excelra Edge comes from a seamless amalgamation of 
proprietary data assets, domain expertise and, data science to accelerate drug 
discovery and development. For more information, visit www.excelra.com. 

    For media inquiries, contact: 
    Jigesh Shah
    Jigesh.shah@excelra.com 
    +91-9820444994 

    Logo: https://mma.prnewswire.com/media/1599641/GOSTAR_Logo.jpg 

    Source: Excelra Knowledge Solutions Pvt Ltd 
Translations

Japanese